Filters

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2001;6(12):661-9

Free Full Text

Abstract

Telithromycin in lower respiratory tract infections.

F Blasi, M Cazzola, P Tarsia, S Aliberti, C Baldessari, V Valenti

Future microbiology 2007;1(1):7-16

Full Text

Abstract

Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline.

Jerry M Zuckerman, Fozia Qamar, Bartholomew R Bono

Infectious disease clinics of North America 2010;23(4):997-1026, ix-x

Full Text

Abstract

Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of macrolide antibiotics: a review of published cases.

Ana V Pejčić

International journal of dermatology 2021;60(1):12-24

Full Text

Abstract

The emerging new generation of antibiotic: ketolides.

P Zhong, V Shortridge

Current drug targets. Infectious disorders 2002;1(2):125-31

Full Text

Abstract

Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses.

F Namour, D H Wessels, M H Pascual, D Reynolds, E Sultan, B Lenfant

Antimicrobial agents and chemotherapy 2001;45(1):170-5

Free Full Text

Abstract

Clinical use of antimicrobial pharmacodynamic profiles to optimise treatment outcomes in community-acquired bacterial respiratory tract infections: application to telithromycin.

David P Nicolau

Expert opinion on pharmacotherapy 2004;5(2):229-35

Full Text

Abstract

Results: 1 – 15 / 119

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Ketolides""[mesh_terms]

Telithromycin new product overview.

Telithromycin-induced acute interstitial nephritis: a first case report.

Penetration of oral telithromycin into female genital tissues.

Benefit-risk assessment of telithromycin in the treatment of community-acquired pneumonia.

Telithromycin: the first ketolide antibacterial for the treatment of community-acquired respiratory tract infections.

Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogens.

13--Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents.

Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes.

Ketolides-telithromycin, an example of a new class of antibacterial agents.

Telithromycin in lower respiratory tract infections.

Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline.

Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of macrolide antibiotics: a review of published cases.

The emerging new generation of antibiotic: ketolides.

Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses.

Clinical use of antimicrobial pharmacodynamic profiles to optimise treatment outcomes in community-acquired bacterial respiratory tract infections: application to telithromycin.

Results for
""Ketolides""[mesh_terms]